The GLP-1 Paradox: Understanding the Complex Relationship Between Weight-Loss Drugs and Bone Health
For millions of Americans navigating the complexities of obesity and type 2 diabetes, the emergence of GLP-1 receptor agonists—such as Ozempic, Wegovy, and Zepbound—has been nothing short of a medical…
